Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Kiora Pharmaceuticals Inc KPRX

Healthcare Biotechnology
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also... see more

Current News (NDAQ:KPRX)

Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds

Newsfile 9 days ago

Kiora Pharmaceuticals Reports Third Quarter 2025 Results; Company Advances Pipeline with Two Actively Enrolling Phase 2 Clinical Trials for Retinal Diseases

Newsfile November 7, 2025

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders

PR Newswire October 30, 2025

Kiora Pharmaceuticals to Participate in the 2025 Maxim Growth Summit and Eyecelerator @ AAO 2025

Newsfile October 15, 2025

Kiora Pharmaceuticals to Webcast On-Demand Presentation at The H.C. Wainwright 27th Annual Global Investment Conference

Newsfile September 4, 2025

Kiora Pharmaceuticals Reports Second Quarter 2025 Results; Company Advances Pipeline with Two Active Phase 2 Clinical Trials for Retinal Diseases

Newsfile August 8, 2025

Kiora Pharmaceuticals to Showcase Its Retinal Disease Therapeutic Pipeline at The H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

Newsfile August 7, 2025

Kiora Pharmaceuticals Granted U.S. Patent Expanding Protection for KIO-104 in the Treatment of Ocular Disease

Newsfile July 22, 2025

Kiora Pharmaceuticals and Senju Pharmaceutical Partner on KIO-301 for the Treatment of Retinal Diseases in Asia

Newsfile June 3, 2025
View More News ››

Opinion & Analysis (NDAQ:KPRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:KPRX)

Using technical analysis for this stock.

It is signalling a big upswing for shareholders this morning,so good luck to all
coolfooldumbguy - June 3, 2025

The correct symbol for this stock is KPRX

Otherwise the company name is Kiora Pharm
coolfooldumbguy - June 3, 2025

Buy buddy buy because it's taking off this morning.

Otherwise you guys will be missing out on this stock today
coolfooldumbguy - June 3, 2025

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX): Developing Innova

http://beyondspx.com/2024/07/31/kiora-pharmaceuticals-inc-nasdaqkprx-developing-innovative-ophthalmic-therapies-with-promising-pipeline/
MikeTester - August 2, 2024

KPRX.....this has been all over the map this a.m ; )

This is what these "thinners" do Just an observation No position.....yet ; )  Cheers !
Iseneschal - February 17, 2023

KPRX.....Bouncing off the low diring PM trading... $7.79

Ya never know  Me no position Ski day ; )
Iseneschal - February 9, 2023
View more Bullboard ››

Coelacanth Energy Inc.

Coelacanth Energy Inc.

Coelacanth Energy Inc., an oil and natural gas company, engages in the acquisition, development, exploration, and production ...
View More »